[1] Liu X, Yao J, Song L, et al. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade. J Immunother Cancer, 2019, 7(1):204. [2] Zhang XF, Bagante F, Chen Q, et al. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma. Surgery, 2018, 163(5):1114-1120. [3] 安澜, 冉显会, 郑荣寿, 等. 中国肝细胞癌和肝内胆管细胞癌临床诊疗情况比较研究.中国癌症防治杂志, 2021, 13(2): 126-132. [4] Sha M, Jeong S, Xia Q. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis. Liver Transpl, 2020, 26(9):1202-1203. [5] Lu J, Li B, Li FY, et al. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated? Eur J Surg Oncol, 2019, 45(11):2173-2179. [6] Li H, Hu B, ZhouZQ, et al. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World J Surg Oncol, 2015, 13:161. [7] 闫加艳, 陈炜, 王坚, 等. 顺逆结合肝门显露法治疗侵犯肝门的肝内胆管细胞癌. 中华消化外科杂志, 2017, 16(4): 417-422. [8] Kang SH, Choi Y, Lee W, et al. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching. Surg Oncol, 2020, 33:63-69. [9] Ratti F, Rawashdeh A, Cipriani F, et al. Intrahepatic cholangiocarcinoma as the new field of implementation of laparoscopic liver resection programs. A comparative propensity score-based analysis of open and laparoscopic liver resections. Surg Endosc, 2021, 35(4):1851-1862. [10] Zhai ST, Liang X, Mao QJ, et al. A retrospective pilot study to examine the feasibility of real-time navigation for laparoscopic liver resections in intrahepatic cholangiocarcinoma using fusion indocyanine green fluorescence imaging. J Surg Oncol, 2020, 122(2):226-233. [11] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 中华消化外科杂志, 2020, 19(1): 1-20. [12] 吴舟桥, 王琦, 石晋瑶, 等. 欧美国家胃癌手术并发症的诊断标准及风险评估. 中华胃肠外科杂志, 2017, 20(2): 135-139. [13] 陈骏, 毛谅, 何健, 等. 第8版《美国癌症联合会肿瘤分期手册》肝内胆管细胞癌TNM分期解读. 中华消化外科杂志, 2017, 16(4):330-335. [14] Balitzer D, Joseph NM, Ferrell L, et al. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma. Mod Pathol, 2019, 32(10):1486-1494. [15] Burt AD, Alves V, Bedossa P, et al. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 2018, 73(3):369-385. [16] Lee W, Park JH, Kim JY, et al. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc, 2016, 30(11):4835-4840. [17] Wu J, Han J, Zhang Y, et al. Safety and feasibility of laparoscopic versus open liverresection with associated lymphadenectomy for intrahepatic cholangiocarcinoma. Biosci Trends, 2020, 14(5):376-383. [18] 陈泰安, 杨发才, 李梦, 等. 腹腔镜肝切除术治疗肝内胆管细胞癌的安全性及疗效分析. 中华肝胆外科杂志, 2021,27(7):485-488. [19] Tan SY, Visvanathan S, Abu Hassan R, et al. Autophagic degradation of misfolded nuclear receptor co-repressor (NCoR) is linked to the growth of tumor cells in HBX positive hepatocellular carcinoma (HCC). Front Oncol, 2019,9:1335. [20] Guerrini GP, Esposito G, Tarantino G, et al. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: the first meta-analysis. Langenbecks Arch Surg, 2020, 405(3):265-275. |